Bain Capital Life Sciences Fund II, L.P.
Boston, MA · CIK 1773187 · 13F filing filed 2026-08-14
- Legal entityBAIN CAPITAL LIFE SCIENCES FUND II, L.P. (KY)
For Q2 2026 this manager filed a 13F notice: its holdings were reported by another manager.
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| XILIO THERAPEUTICS INC XLO · 13G · filed 2026-05-15 | 10.0%≈ $6.1m |
| SAVARA INC SVRA · 13D · filed 2025-03-27 | 10.0%≈ $108.4m |
| XILIO THERAPEUTICS INC 13G · filed 2026-02-17 | 8.5% |
| C4 THERAPEUTICS INC CCCC · 13G · filed 2025-10-24 | 6.2%≈ $28.3m |